Skip to main content
Log in

The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The efficacy and tolerability of aceclofenac (100 mg bid; n=109), a new non-steroidal anti-inflammatory agent, was compared to that of indomethacin (50 mg bid; n=110) in a multi-centre, 12-week, randomized, double-blind clinical trial in patients with rheumatoid arthritis. The efficacy of aceclofenac, on the basis of several clinical features characteristic for rheumatoid arthritis, was comparable to that of indomethacin. Patients in both treatment groups showed a notable and significant improvement during the study. Under aceclofenac treatment, the number of painful and swollen joints decreased by a median of six and nine, respectively, morning stiffness was shortened by 1 h, and the grip strength of both hands increased by a median of 8 mmHg. Pain at rest was relieved in 65.3% of aceclofenac-treated patients and in 67.1% of those treated with indomethacin (n.s.). With regard to safety, aceclofenac tended to be better tolerated than indomethacin. Among the 109 aceclofenac-treated patients, 26 incidents of adverse effects due to the drug were noted in 20 patients (18.4%). Sixty-four incidents of adverse events were documented in 32 (29.1%) of the 110 patients treated with indomethacin. The most common adverse events reported during treatment with aceclofenac were heartburn (four patients) and vertigo (three patients).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zvaifler NL (1973) The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:256–356

    Google Scholar 

  2. Grau M, Guasch J, Montero JL, Felipe A, Carrasco E, Juliá S (1991) Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac. Arzneimittelforschung/Drug Res 41:1265–1276

    Google Scholar 

  3. Cecchettin M, Cerea P, Torri G (1988) Therapeutic efficacy of aceclofenac and diclofenac in acute knee arthroses. Study of the E2-prostaglandin levels in the synovial fluid and in the serum. Clin Trials J 25:144–151

    Google Scholar 

  4. Díaz C, Rodríguez A, Geli C, Llobet JM, Tapounet R (1988) Comparison of aceclofenac and diclofenac in osteoarthritic pain. Curr Ther Res 44:252–256

    Google Scholar 

  5. Torrejón VA (1988) Treatment of severe rheumatic pain with aceclofenac: results of a comparative study vs placebo. Acta Ther 14:275–280

    Google Scholar 

  6. Sainz Olalla F (1989) Ahalgesic efficacy of aceclofenac. Double-blind study vs placebo in the treatment of odontalgia. Curr Ther Res 43:900–902

    Google Scholar 

  7. Bubani G (1988) The analgesic activity and tolerability of aceclofenac in the treatment of odontalgia. Clin Trials J 23: 244–253

    Google Scholar 

  8. Movilia PG (1988) Evaluation of analgesic activity and tolerability of aceclofenac in the treatment of postepisiotomy pain. Drugs Exp Clin Res 15:47–51

    Google Scholar 

  9. Ballesteros R, Ansoleaga JJ, Tapounet R (1990) The efficacy and tolerance of aceclofenac in rheumatoid arthritis. A double-blind study vs placebo. Clin Trials J 27:12–19

    Google Scholar 

  10. Giorgianni G, Ottaviani C, Soliano A, Campi N (1992) Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. Curr Ther Res 51:175–183

    Google Scholar 

  11. Wassif W, Bjarnason I (1992) A comparison of the effects of aceclofenac and diclofenac on gastrointestinal blood loss. Br J Clin Res 3:109–114

    Google Scholar 

  12. Grupo de Estudio de Artritis Reumatoide (1992) Estudio de eficacia y tolerancia de aceclofenaco frente a ketoprofeno en el tratamiento de la artritis reumatoide. Rev Esp Reumatol 19: 263–268

    Google Scholar 

  13. Fehr K, Miehle W, Schattenkirchner M, Tillmann K (1989) Rheumatologie in Praxis und Klinik. Thieme, Stuttgart

    Google Scholar 

  14. Martín-Mola E, Gijón-Baños J (1995) Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. Rheumatol Int 15:111–116

    Google Scholar 

  15. Furst DE, Dromgoole SH (1987) Indomethacin and sulindac. In: Paulus HE, Furst DE, Dromgoole SH (eds) Drugs for rheumatic disease. Churchill Livingstone. New York, pp 285–314

    Google Scholar 

  16. Anonymous (1994) Current problems in pharmacovigilance, vol 20. U. K. Committee on Safety of Medicines

  17. Gøtzsche PC (1989) Patients' preference in indomethacin trials: an overview. Lancet 1:88–91

    Google Scholar 

  18. Accardo S, Seriolo B, Tirri G, Colombo B, Fumagali M, Lotti G, Pagliara L, Parnham MJ, Alepuz M (1995) Long term safety profile of aceclofenac in the treatment of articular pain. Eur J Rheumatol Inflam 15:35–41

    Google Scholar 

  19. Lichtenstein DR, Syngal S, Wolfe MM (1995) Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum 38:5–18

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kornasoff, D., Maisenbacher, J., Bowdler, J. et al. The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis. Rheumatol Int 15, 225–230 (1996). https://doi.org/10.1007/BF00290375

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00290375

Key words

Navigation